Suspended
Resistance Exercise Effect on Physical Performance and Functional Status in Sarcopenic Older Women
What is being tested
Resistance Exercise Group
Other
Who is being recruted
Atrophy+8
+ Behavior
+ Muscular Atrophy
Over 70 Years
+14 Eligibility Criteria
How is the trial designed
Treatment Study
Interventional
Summary
Principal SponsorNational Institute of Medical Sciences and Nutrition, Salvador Zubiran
Last updated: April 22, 2015
Sourced from a government-validated database.Claim as a partner
Study withdrawn.
Principal SponsorNational Institute of Medical Sciences and Nutrition, Salvador Zubiran
Last updated: April 22, 2015
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Female
Biological sex of participants that are eligible to enroll.Over 70 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
AtrophyBehaviorMuscular AtrophyNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPathological Conditions, AnatomicalNeuromuscular ManifestationsMotor ActivitySarcopenia
Criteria
3 inclusion criteria required to participate
Body mass composition by BIA with skeletal muscle mass < 6.76kg/m2
Handgrip strength (adjusted for BMI) less than 20kg
Speed gait of < 0.8m/sec
11 exclusion criteria prevent from participating
Current diagnosis of malnutrition (BMI < 19kg/m2)
Decompensated heart failure (NYHA III or IV)
Dementia (any type, moderate or severe stage)
Exacerbation of chronic obstructive pulmonary disease
Show More Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
No InterventionGeneral information about sarcopenia will be provided to the participants, as well as general recommendations of healthy habits.
We will contact the participants weekly by phone to answer questions about sarcopenia, and remind them of their next appointment and about adverse events occured during this period of time.
The frequent contact with the participants has also the purpose to prevent losses or rejections for future evaluations
Group II
ExperimentalAn individualized resistance exercise program wil be applied twice a week by an expert physiotherapist. Every 2 weeks, intensity will be reassessed by the same physiotherapist. Weekly, participants will be asked about incidents such as the occurrence of falls or hospitalizations during this study period.
Physical performance and functional status will be assessed by the blind investigator at weeks 6,12 and 24
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
National Institue of Medical Sciences and Nutrition Salvador Zubirán
Mexico City, MexicoOpen National Institue of Medical Sciences and Nutrition Salvador Zubirán in Google MapsSuspendedOne Study Center